Switzerland halts arms exports to US over Iran war, citing neutrality

In a significant diplomatic move underscoring its commitment to neutrality, Switzerland has formally suspended authorization of new arms exports to the United States due to Washington’s involvement in the ongoing Middle East conflict. The Swiss government announced on Friday that its domestic legal framework and longstanding policy of neutrality prevent it from approving weapons transfers to nations engaged in international armed conflicts.

The decision specifically references U.S. military involvement in the region and constitutes a formalization of practices already in effect since the conflict’s escalation on February 28. While the measure pauses fresh approvals for arms and ammunition shipments, it does not constitute a comprehensive embargo. Existing export licenses deemed unrelated to the current conflict remain valid and operational.

An interministerial expert team will continuously monitor developments and assess whether additional actions are required under Swiss neutrality laws. This review extends beyond conventional weaponry to include goods regulated by the Goods Control Act, dual-use items, and non-controlled commodities affected by Iranian sanctions.

The United States represents Switzerland’s second-largest defense market, accounting for approximately 10% of its arms exports in the previous year. These shipments have included aerial drones, various ammunition types, and small arms.

This stance aligns with Switzerland’s consistent application of neutrality principles, as demonstrated in its position regarding Ukraine. Bern has previously refused requests from allied nations to re-export Swiss-manufactured weapons to Kyiv, citing legal restrictions that have caused friction with European partners and concerns within Switzerland’s defense industry about potential exclusion from key supply chains.

Although Swiss legislators endorsed proposals in December to relax arms export rules for a predefined group of 25 countries including the U.S., these regulatory modifications have not yet been implemented and could potentially face a public referendum.